Dayanan, Albert T.
HRN: 20-72-87 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/01/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
12/01/2023
12/08/2023
IV
2.25g
Q8
Sepsis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes